ACQUIRE ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE Trademark

Trademark Overview

On Wednesday, October 29, 2014, a trademark application was filed for ACQUIRE ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE with the United States Patent and Trademark Office. The USPTO has given the ACQUIRE ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE trademark a serial number of 86437926. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 29, 2024. This trademark is owned by Bristol-Myers Squibb Company. The ACQUIRE ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

General Information

Serial Number86437926
Word MarkACQUIRE ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE
Filing DateWednesday, October 29, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 29, 2024
Registration Number5469931
Registration DateTuesday, May 15, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

NOT AVAILABLE"ABATACEPT COMPARISON OF SUB(QU)CUTANEOUS VS. INTRAVENOUS IN INADEQUATE RESPONDERS TO METHOTREXATE"
Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 29, 2024
Primary Code042
First Use Anywhere DateMonday, October 31, 2011
First Use In Commerce DateMonday, October 31, 2011

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Saturday, February 7, 2015NON-FINAL ACTION WRITTEN
Saturday, November 1, 2014NEW APPLICATION ENTERED
Friday, November 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 31, 2015ASSIGNED TO EXAMINER
Saturday, February 7, 2015NON-FINAL ACTION E-MAILED
Saturday, February 7, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 17, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, August 17, 2015PETITION TO REVIVE-GRANTED
Monday, August 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 18, 2015NOTICE OF REVIVAL - E-MAILED
Friday, August 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2015ASSIGNED TO LIE
Friday, September 18, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 22, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 22, 2016SOU EXTENSION 1 FILED
Wednesday, June 22, 2016SOU EXTENSION 1 GRANTED
Friday, June 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 22, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2016SOU EXTENSION 2 FILED
Thursday, December 22, 2016SOU EXTENSION 2 GRANTED
Saturday, December 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2017SOU EXTENSION 3 FILED
Thursday, June 22, 2017SOU EXTENSION 3 GRANTED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, December 20, 2017SOU EXTENSION 4 FILED
Wednesday, December 20, 2017SOU EXTENSION 4 GRANTED
Friday, December 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, March 15, 2018SOU TEAS EXTENSION RECEIVED
Thursday, March 15, 2018SOU EXTENSION 5 FILED
Thursday, March 15, 2018USE AMENDMENT FILED
Thursday, March 22, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 22, 2018SOU EXTENSION 5 GRANTED
Thursday, March 22, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, March 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 11, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 12, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 15, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 15, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 29, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

inadequate responders methotrexate intravenous cutaneous abatacept comparison acquire pharmaceuticals clinical trials field information medical scientific research providing